Top news of the week: 19.05.2020.
#pharmaceuticals #lifesciences #biospace #biotechnology #CoronaOutbreak #CoronaPandemic #CoronaVirus #COVID19 #SkilledWorkforce #biotech
Companies And Industries
RT @investindiaROK: #NewIndia has the highest no. of @US_FDA approved drug manufacturing units. With low-cost production capability & a #SkilledWorkforce, India is an important #manufacturing base for global #biotech companies. Visit: https://t.co/QR1ZqcmkEr #InvestInIndia #GrowWithIndia @BIRAC_2012 https://t.co/IjpqdTzIKf
OpenBiotechnology
India is among the top 12 destinations for biotechnology in the world, with approximately 3% share in the global Biotechnology industry. India is also the leader in the global supply of ...
Biopharma Update on the Novel Coronavirus: May 15
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/Mtnr00VG5e
OpenBiopharma Update on the Novel Coronavirus: May 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 15, 2020.
Biopharma Update on the Novel Coronavirus: May 14
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/BRH2iICnr1
OpenBiopharma Update on the Novel Coronavirus: May 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 14, 2020.
Lava Therapeutics and Janssen Biotech to Collaborate on Cancer Treatment Research https://t.co/7Yise2V6Qf https://t.co/a2daQz068Q
OpenLava Therapeutics and Janssen Biotech to Collaborate on Cancer Treatment Research
The goal is to discover and develop novel bispecific antibodies to gamma-delta T cells for the treatment of cancer.
Legend Biotech Aims for $100 Million IPO
#biospace #lifesciences #biotechnology #pharmaceuticals
https://t.co/mN85jUcrUE
OpenLegend Biotech Aims for $100 Million IPO
Legend Biotech, a clinical stage oncology biotech company, filed with the U.S. Securities and Exchange Commission on Wednesday to raise up to $100 million in an initial public offering.
China CAR T firm Legend Biotech eyes $100M Nasdaq listing
BEIJING – Legend Biotech Corp., headquartered in Somerset, N.J., filed with the U.S. SEC last week plans to raise up to $100 million to advance its BCMA-targeting CAR T candidate, ...
Join our experts on June 11 to learn about how KBI’s HCP pAb libraries can be customized to specific products to increase ELISA method performance and HCP coverage. Register for Part II of our HCP webinar series now: https://t.co/H7LtVAmCP3
OpenJune 11, 2020 11:00am ET | A Novel Approach to Development of Process and Product Targeted HCP Reagents
A Novel Approach to Development of Process and Product Targeted HCP Reagents
J&J-backed CAR-T biotech Legend guns for $100M IPO but sees CRS death in early trial https://t.co/4e40uJIuaE https://t.co/UpLNx5nJTg
OpenJ&J-backed CAR-T biotech Legend guns for $100M IPO but sees CRS death in early trial
Legend Biotech is hoping it can ride the biotech IPO wave and take in a cool $100 million for its cell therapy work.